help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yen, P. M.
Right arrow Articles by Chin, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yen, P. M.
Right arrow Articles by Chin, W. W.

Endocrinology, Vol 136, 2845-2851, Copyright © 1995 by Endocrine Society


ARTICLES

Studies on the repression of basal transcription (silencing) by artificial and natural human thyroid hormone receptor-beta mutants

PM Yen, EC Wilcox, Y Hayashi, S Refetoff and WW Chin
Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

Thyroid hormone receptors (TRs) are ligand-dependent transcription factors that regulate target gene transcription. Interestingly, in the absence of ligand, TRs also can repress basal transcription of positively regulated target genes, suggesting that unliganded TR may have a distinct role in gene regulation. In this paper, DNA binding, truncation, and natural human TR beta mutants were used in cotransfection and electrophoretic mobility shift assays to study various aspects of TR-mediated basal repression. Presently, little is known about the role(s) of natural human TR beta mutants on basal repression. These results show that: 1) TR binding to DNA likely is required for basal repression; 2) the amino-terminal region of TR is not required for basal repression; 3) TR homodimer binding is not absolutely required for basal repression, as TR mutants that selectively form TR-retinoid X receptor heterodimers can mediate basal repression; and 4) TR mutants with poor T3-binding affinity likely have constitutive basal repression, even in the presence of ligand. These findings provide new insight on the mechanism of basal repression by unliganded TRs.


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
G. M. Santos, V. Afonso, G. B. Barra, M. Togashi, P. Webb, F. A. R. Neves, N. Lomri, and A. Lomri
Negative Regulation of Superoxide Dismutase-1 Promoter by Thyroid Hormone
Mol. Pharmacol., September 1, 2006; 70(3): 793 - 800.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. Skorija, M. Cox, J. M. Sisk, D. R. Dowd, P. N. MacDonald, C. C. Thompson, and M. B. Demay
Ligand-Independent Actions of the Vitamin D Receptor Maintain Hair Follicle Homeostasis
Mol. Endocrinol., April 1, 2005; 19(4): 855 - 862.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. A. Phillips, P. Rotman-Pikielny, J. Lazar, S. Ando, P. Hauser, M. C. Skarulis, F. Brucker-Davis, and P. M. Yen
Extreme Thyroid Hormone Resistance in a Patient with a Novel Truncated TR Mutant
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5142 - 5147.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. M. Yen
Physiological and Molecular Basis of Thyroid Hormone Action
Physiol Rev, July 1, 2001; 81(3): 1097 - 1142.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. N. Cohen, A. Putney, F. E. Wondisford, and A. N. Hollenberg
The Nuclear Corepressors Recognize Distinct Nuclear Receptor Complexes
Mol. Endocrinol., June 1, 2000; 14(6): 900 - 914.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. Gurnell, O. Rajanayagam, M. Agostini, R. J. D. Clifton-Bligh, T. Wang, P. M. J. Zelissen, F. van der Horst, A. v. d. Wiel, E. Macchia, A. Pinchera, et al.
Three Novel Mutations at Serine 314 in the Thyroid Hormone {beta} Receptor Differentially Impair Ligand Binding in the Syndrome of Resistance to Thyroid Hormone
Endocrinology, December 1, 1999; 140(12): 5901 - 5906.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
T. Tagami, W.-X. Gu, P. T. Peairs, B. L. West, and J. L. Jameson
A Novel Natural Mutation in the Thyroid Hormone Receptor Defines a Dual Functional Domain That Exchanges Nuclear Receptor Corepressors and Coactivators
Mol. Endocrinol., December 1, 1998; 12(12): 1888 - 1902.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
R. E. Weiss, Y. Murata, K. Cua, Y. Hayashi, H. Seo, and S. Refetoff
Thyroid Hormone Action on Liver, Heart, and Energy Expenditure in Thyroid Hormone Receptor {beta}-Deficient Mice
Endocrinology, December 1, 1998; 139(12): 4945 - 4952.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Liu, A. Takeshita, S. Misiti, W. W. Chin, and P. M. Yen
Lack of Coactivator Interaction Can Be a Mechanism for Dominant Negative Activity by Mutant Thyroid Hormone Receptors
Endocrinology, October 1, 1998; 139(10): 4197 - 4204.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Tagami, P. Kopp, W. Johnson, O. K. Arseven, and J. L. Jameson
The Thyroid Hormone Receptor Variant {alpha}2 Is a Weak Antagonist because It Is Deficient in Interactions with Nuclear Receptor Corepressors
Endocrinology, May 1, 1998; 139(5): 2535 - 2544.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Tagami and J. L. Jameson
Nuclear Corepressors Enhance the Dominant Negative Activity of Mutant Receptors That Cause Resistance to Thyroid Hormone
Endocrinology, February 1, 1998; 139(2): 640 - 650.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Liu, A. Takeshita, T. Nagaya, A. Baniahmad, W. W. Chin, and P. M. Yen
An Inhibitory Region of the DNA-Binding Domain of Thyroid Hormone Receptor Blocks Hormone-Dependent Transactivation
Mol. Endocrinol., January 1, 1998; 12(1): 34 - 44.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
H.-Y. Lin, P. M. Yen, F. B. Davis, and P. J. Davis
Protein synthesis-dependent potentiation by thyroxine of antiviral activity of interferon-gamma
Am J Physiol Cell Physiol, October 1, 1997; 273(4): C1225 - C1232.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. E. Weiss, D. Forrest, J. Pohlenz, K. Cua, T. Curran, and S. Refetoff
Thyrotropin Regulation by Thyroid Hormone in Thyroid Hormone Receptor {beta}-Deficient Mice
Endocrinology, September 1, 1997; 138(9): 3624 - 3629.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
G. Lazennec, T. R. Ediger, L. N. Petz, A. M. Nardulli, and B. S. Katzenellenbogen
Mechanistic Aspects of Estrogen Receptor Activation Probed with Constitutively Active Estrogen Receptors: Correlations with DNA and Coregulator Interactions and Receptor Conformational Changes
Mol. Endocrinol., August 1, 1997; 11(9): 1375 - 1386.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Behr, D. B. Ramsden, and U. Loos
Deoxyribonucleic Acid Binding and Transcriptional Silencing by a Truncated c-erbA{beta}1 Thyroid Hormone Receptor Identified in a Severely Retarded Patient with Resistance to Thyroid Hormone
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1081 - 1087.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. J. Torrance, S. J. Usala, J. E. Pessin, and G. L. Dohm
Characterization of a Low Affinity Thyroid Hormone Receptor Binding Site within the Rat GLUT4 Gene Promoter
Endocrinology, March 1, 1997; 138(3): 1215 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. M. Yen, Y. Liu, J. J. Palvimo, M. Trifiro, J. Whang, L. Pinsky, O. A. Jänne, and W. W. Chin
Mutant and Wild-Type Androgen Receptors Exhibit Cross-Talk on Androgen-, Glucocorticoid-, and Progesterone-Mediated Transcription
Mol. Endocrinol., February 1, 1997; 11(2): 162 - 171.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Ikeda, E. C. Wilcox, and W. W. Chin
Different DNA Elements Can Modulate the Conformation of Thyroid Hormone Receptor Heterodimer and Its Transcriptional Activity
J. Biol. Chem., September 20, 1996; 271(38): 23096 - 23104.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. M. Yen, Y. Liu, A. Sugawara, and W. W. Chin
Vitamin D Receptors Repress Basal Transcription and Exert Dominant Negative Activity on Triiodothyronine-mediated Transcriptional Activity
J. Biol. Chem., May 3, 1996; 271(18): 10910 - 10916.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. T. Baumann, P. Maruvada, G. L. Hager, and P. M. Yen
Nuclear Cytoplasmic Shuttling by Thyroid Hormone Receptors. MULTIPLE PROTEIN INTERACTIONS ARE REQUIRED FOR NUCLEAR RETENTION
J. Biol. Chem., March 30, 2001; 276(14): 11237 - 11245.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society